News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
109–144
Matches
895
Sources here
22
Companies here
13
Search results Stored financial headlines

Active search

895 matching headlines

Ticker or company: XEMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Form 8K Lexeo Therapeutics Inc For: 12 August By Investing.com

The article reports that Lexeo Therapeutics Inc. filed a Form 8K on August 12. It briefly mentions the company name and filing date, without providing further details on the content of the filing. The article is very short and seems to act as a …

LXEO main company
Sharemaestro market context Price below Trend Line 52 weeks -1.2% · Next-week setup negative 42.1% LXEO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lexeo Therapeutics, Inc. 2Q 2026: Net loss $25.9M, EPS $(0.30) — 10-Q Summary

Lexeo Therapeutics, Inc. reported a net loss of $25.9 million and an EPS of $(0.30) for the second quarter of 2026, remaining pre-revenue. The company highlighted clinical progress for LX2006 and LX2020, including the initiation of a pivotal trial for LX2006 and RMAT designation …

LXEO main company
Sharemaestro market context Price below Trend Line 52 weeks -1.2% · Next-week setup negative 42.1% LXEO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights

Lexeo Therapeutics announced its second quarter 2026 financial results and operational highlights, focusing on advancements in its gene therapy pipeline. Key achievements include the initiation of the pivotal SUNRISE-FA 2 trial for LX2006 in Friedreich ataxia cardiomyopathy and the FDA's RMAT designation for LX2020 …

LXEO main company
Sharemaestro market context Price below Trend Line 52 weeks -1.2% · Next-week setup negative 42.1% LXEO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LXEO: Gene therapies for rare cardiac diseases advance with strong data, pipeline, and financial runway

Lexeo Therapeutics (LXEO) is focused on gene therapies for rare cardiac diseases, with a pipeline that includes two clinical-stage and two preclinical programs. Its lead candidates, LX2006 and LX2020, are showing promising efficacy and safety data, with key milestones anticipated. The company reports strong …

LXEO main company
Sharemaestro market context Price below Trend Line 52 weeks -1.2% · Next-week setup negative 42.1% LXEO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Three Nexxen Executives Take New Roles Across Its Ad Platform

Nexxen (NASDAQ: NEXN) has announced key executive appointments to drive the next phase of growth for its unified, AI-driven advertising platform. Chance Johnson is now President, Kara Puccinelli is Chief Commercial Officer, and Kenneth Suh is Chief Business Officer. These changes aim to strengthen …

NEXN main company
Sharemaestro market context Trend signal active 52 weeks +2.9% NEXN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AQR Capital discloses 11.0M-share Exelixis (EXEL) position at 4.39% ownership

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have disclosed a beneficial ownership of 11,023,943 shares of Exelixis, Inc. common stock, representing 4.39% of the class. The filing indicates shared voting power over 10,935,221 shares and shared dispositive power over all 11,023,943 …

EXEL main company
Sharemaestro market context Trend signal active 52 weeks +32.6% · Next-week setup positive 55.4% EXEL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MarketAxess (NASDAQ:MKTX) Rating Lowered to Hold at Keefe, Bruyette & Woods

Keefe, Bruyette & Woods downgraded MarketAxess (NASDAQ:MKTX) from "moderate buy" to "hold," aligning with a broader analyst consensus of "Hold" and an average price target of $156.10. Despite the downgrade, MarketAxess recently exceeded quarterly earnings expectations, reporting EPS of $1.95 against an estimate of …

MKTX main company
Sharemaestro market context New activity signal 52 weeks -12.6% MKTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

We Think Crexendo's (NASDAQ:CXDO) Profit Is Only A Baseline For What They Can Achieve

Crexendo, Inc. (NASDAQ:CXDO) recently posted solid earnings, but the market appears to be overly pessimistic. Analysis shows that the company's statutory earnings are likely conservative due to a negative accrual ratio and the impact of unusual items. However, shareholder dilution from new share issuance …

CXDO main company
Sharemaestro market context Price below Trend Line 52 weeks +9.0% · Next-week setup positive 65.4% CXDO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pixelworks Inc (PXLW) Stock News Today

This article provides recent news and financial updates for Pixelworks Inc (PXLW). It highlights the company's Q2 2026 earnings report, noting a decline in revenue and a widening operating loss. The page also displays current stock metrics and links to various financial data points …

PXLW main company
Sharemaestro market context New activity signal 52 weeks -16.4% · Next-week setup negative 41.8% PXLW stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Dimensional Fund Advisors LP Increases Holdings in Lexeo Therapeutics, Inc. $LXEO

Dimensional Fund Advisors LP significantly increased its stake in Lexeo Therapeutics, Inc. during the first quarter, now owning 1.41% of the company's shares. Despite this institutional interest, Lexeo insiders, including the CEO, recently sold shares primarily to cover tax obligations on vested equity awards. …

LXEO main company
Sharemaestro market context Price below Trend Line 52 weeks -1.2% · Next-week setup negative 42.1% LXEO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Axe Compute (AGPU.US) will release its earnings report before the market opens on August 17.

Axe Compute (AGPU.US) is scheduled to release its earnings report before the market opens on August 17. This announcement provides investors with a heads-up on when to expect the company's latest financial results.

AGPU main company
Sharemaestro market context Trend signal active 52 weeks -40.7% · Next-week setup negative 42.5% AGPU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

(NEWT) Movement as an Input in Quant Signal Sets

Newtekone Inc. (NASDAQ: NEWT) is showing weak near and mid-term sentiment but a strong long-term outlook, with support currently being tested. The article details three AI-generated trading strategies (Position, Momentum Breakout, Risk Hedging) and provides multi-timeframe signal analysis, highlighting a 38.5:1 risk-reward setup. Investors …

NEWTI main company
Sharemaestro market context Trend signal active 52 weeks +8.1% · Next-week setup positive 56.3% NEWTI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Q1 2026 Deluxe Corp Earnings Call Transcript

This article provides the edited transcript for Deluxe Corp's Q1 2026 earnings call, which took place on May 6, 2026, at 12:30 PM GMT. The call was hosted by Vice President of Strategy and Investor Relations, Brian Anderson, and included President and CEO Barry …

DLX main company
Sharemaestro market context Price below Trend Line 52 weeks +24.8% · Next-week setup positive 60.2% DLX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Crexendo Inc (CXDO) (Q2 2026) Earnings Call Highlights: Revenue Surges 49% as Platform Wins ...

Crexendo reported strong Q2 2026 results with a 49% revenue increase to $24.6 million, driven by the ESI acquisition and growth in telecom services. The company achieved GAAP net income of $1.1 million and a substantial increase in new platform customers, securing 11 new …

CXDO main company
Sharemaestro market context Price below Trend Line 52 weeks +9.0% · Next-week setup positive 65.4% CXDO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pixelworks expects cash operating expenses below $2.5M per quarter in 2026 while adding a new multiyear device certification deal

Earnings Call Insights: Pixelworks (PXLW) Q2 2026 MANAGEMENT VIEW * "Having completed our strategic transformation of Pixelworks earlier this year, Q2 represented our first full quarter of operations as a pure-play technology licensing company." (President, CEO & Chairman Todd DeBonis) * "As previously conveyed, …

PXLW main company
Sharemaestro market context New activity signal 52 weeks -16.4% · Next-week setup negative 41.8% PXLW stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Crexendo (CXDO) Q2 2026 Earnings Call Transcript

Crexendo reported strong Q2 2026 results with a 49% revenue increase to $24.6 million, driven by the ESI acquisition and growth in telecom services. The company achieved GAAP net income of $1.1 million and a substantial increase in new platform customers, securing 11 new …

CXDO main company
Sharemaestro market context Price below Trend Line 52 weeks +9.0% · Next-week setup positive 65.4% CXDO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings call transcript: Pixelworks Q2 2026 revenue miss, shares edge higher

Pixelworks reported a significant revenue and EPS miss in Q2 2026, posting a loss of $0.44 per share against a forecast of $0.16 and revenue of $64,000 against expectations of $300,000. Despite the miss, shares edged higher after hours, as the company highlighted a …

PXLW main company
Sharemaestro market context New activity signal 52 weeks -16.4% · Next-week setup negative 41.8% PXLW stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Understanding the Setup: (MKTX) and Scalable Risk

This article provides an AI-driven analysis of Marketaxess Holdings Inc. (MKTX), indicating mixed sentiment and choppy conditions across various time horizons. It outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for different risk profiles, complete with entry, target, and stop-loss levels. The …

MKTX main company
Sharemaestro market context New activity signal 52 weeks -12.6% MKTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PIXELWORKS ($PXLW) Releases Q2 2026 Earnings

PIXELWORKS ($PXLW) reported its Q2 2026 earnings, missing analyst estimates for both earnings per share and revenue. The company posted -$0.34 per share against an estimated -$0.20, and revenue of $60,000 versus an estimated $306,000. Following the announcement, the stock price decreased by 9.44%.

PXLW main company
Sharemaestro market context New activity signal 52 weeks -16.4% · Next-week setup negative 41.8% PXLW stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Crexendo (CXDO) is an Incredible Growth Stock: 3 Reasons Why

Crexendo (CXDO) is identified as an incredible growth stock by Zacks' proprietary system, earning a favorable Growth Score and a top Zacks Rank. The company shows strong prospects with an expected EPS growth of 25% this year, crushing the industry average, and an impressive …

CXDO main company
Sharemaestro market context Price below Trend Line 52 weeks +9.0% · Next-week setup positive 65.4% CXDO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How to Play X-Energy Stock Ahead of Q2 Earnings Release?

X-Energy, Inc. XE is expected to report second-quarter 2026 results on Aug. 13, before market open. The Zacks Consensus Estimate for earnings is pegged at a loss of 9 cents per share. The Zacks Consensus Estimate for revenues is pinned at $50.6 million.Zacks Investment …

XE main company
Sharemaestro market context Stored weekly price path 17 weeks -28.2% · Next-week setup negative 39.5% XE stored weekly price path from 24 Apr 2026 to 14 Aug 2026

Xencor stock hits 52-week high at 21.99 USD

Xencor Inc. (XNCR) has reached a new 52-week high of $21.99, demonstrating a 41% year-to-date return and a 178.71% increase over the past year, reflecting strong investor confidence in the biotechnology company. This growth is attributed to its innovative work in engineered monoclonal antibodies …

XNCR main company
Sharemaestro market context Trend signal active 52 weeks +177.5% XNCR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

EXEL SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Exelixis

SueWallSt is investigating potential securities claims against Exelixis (NASDAQ: EXEL) following a reduction and narrowing of its full-year 2026 revenue guidance. The company's shares declined after it cited a slower-than-expected ramp in its neuroendocrine-tumor business, contradicting earlier reiterations of its financial outlook. Shareholders who …

EXEL main company
Sharemaestro market context Trend signal active 52 weeks +32.6% · Next-week setup positive 55.4% EXEL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Crexendo’s cloud communications platform reaches 8M users By Investing.com

Crexendo, Inc. announced its cloud communications platform now supports over 8 million users worldwide, adding approximately one million users in eight months. The platform has grown over 370% since Crexendo acquired NetSapiens in June 2021. The company's platform includes CAIRO, an AI receptionist and …

CXDO main company
Sharemaestro market context Price below Trend Line 52 weeks +9.0% · Next-week setup positive 65.4% CXDO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CXDO Looks 8.2% Undervalued on GF Value™

Crexendo Inc (NASDAQ: CXDO) is currently deemed 8.2% undervalued by GuruFocus' GF Value™, with a current price of $6.30 against an intrinsic value of $6.86. The company recently announced its AI-driven UCaaS platform surpassed 8 million global users, reflecting significant growth. While insider selling …

CXDO main company
Sharemaestro market context Price below Trend Line 52 weeks +9.0% · Next-week setup positive 65.4% CXDO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context